TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bionomen AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
804
|
1,537
|
799 |
| Financial expenses |
1
|
1
|
1 |
| Earnings before taxes |
59
|
275
|
101 |
| EBITDA |
58
|
276
|
103 |
| Total assets |
371
|
454
|
291 |
| Current assets |
369
|
452
|
287 |
| Current liabilities |
63
|
93
|
160 |
| Equity capital |
286
|
338
|
120 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
77.1%
|
74.4%
|
41.2% |
| Turnover per employee |
402
|
768
|
400 |
| Profit as a percentage of turnover |
7.3%
|
17.9%
|
12.6% |
| Return on assets (ROA) |
16.2%
|
60.8%
|
35.1% |
| Current ratio |
585.7%
|
486.0%
|
179.4% |
| Return on equity (ROE) |
20.6%
|
81.4%
|
84.2% |
| Change turnover |
-681
|
735
|
86 |
| Change turnover % |
-46%
|
92%
|
12% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.